health · education · HHS-NIH11

Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required)

National Institutes of Health · PAR-25-167

134 days left

Deadline

January 7, 2027

GRANTQUICK SUMMARYPlain-English Overview

Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required). National Institutes of Health. Through this notice of funding opportunity (NOFO), the National Cancer Institute (NCI) invites applications for support of investigator-initiated clinical trials that have the potential to reduce the burden of cancer through improvements in early detection, screening, prevention and interception,... Funding amounts not specified.

Who Should Apply

For-profit organizations, County governments, Other Native American Tribal Organizations, Small businesses, Nonprofits (non-501c3) (+10 more)

Who Should NOT Apply

Organizations not matching the eligible applicant types listed above

Key Requirements (Plain English)

•Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Is...
•Deadline: 2027-01-07

💡 GrantQuick Tip

Focus your proposal on clear outcomes, alignment with agency priorities, and demonstrate organizational capacity.

Competitiveness: Moderate to high — federal grants are always competitive

What This Grant Funds

Through this notice of funding opportunity (NOFO), the National Cancer Institute (NCI) invites applications for support of investigator-initiated clinical trials that have the potential to reduce the burden of cancer through improvements in early detection, screening, prevention and interception, healthcare delivery, quality of life, and/or survivorship related to cancer; with such attributes, the proposed studies should also have the potential to improve clinical practice and/or public health. Applications submitted to this NOFO must include studies that meet the National Institutes of Health (NIH) definition of a clinical trial (see NOT-OD-15-015 for details) and provide specific clinical trial information as described in this FOA. This NOFO does not and will not support clinical trials for studies of cancer diagnosis and/or oncologic therapy in patients. The proposed investigator-initiated projects should be related to the programmatic interests of the NCI Division of Cancer Prevention and/or the NCI Division of Cancer Control and Population Sciences.

Attachments

PDF

PAR-25-167 Full Announcement Text

PAR-25-167-Full-Announcement.html

Who Can Apply

Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Eligible Applicant Types

For-Profit OrganizationsCounty GovernmentsOther Tribal OrganizationsSmall BusinessesNonprofits without 501(c)(3)State GovernmentsPrivate Colleges & UniversitiesOther (see NOFO for details)501(c)(3) NonprofitsSpecial District GovernmentsIndependent School DistrictsPublic Colleges & UniversitiesFederally Recognized Tribal GovernmentsPublic And Indian Housing AuthoritiesCity/Township Governments

Funding Details

Cost Sharing Required?: No
Funding Instrument: grant

Key Dates

Posted: November 12, 2024

Application Deadline: January 7, 2027 (134 days remaining)

Agency Contact

NIH Grants Information grantsinfo@nih.gov

grantsinfo@nih.gov

Ready to apply?

View the full NOFO and submit your application on Grants.gov

View on Grants.gov